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Cancer of the testis is a malignant tumour, which mainly affects
young men, with a peak incidence at around 30 years of age
(Senturia, 1987; Adami et al, 1994). There are 2 major different
histo-pathological types, seminomas and non-seminomas, the
latter form having an age-specific incidence peak 10 years earlier
(25–29 years of age) than the seminomas (35–39 years of age)
(Forman and Moller, 1994). The incidence rates of testicular
cancer have increased during recent years in many countries
including Great Britain (Coleman et al, 1993; Adami et al, 1994;
Forman and Moller, 1994; Devesa et al, 1995), although there is
some evidence of a leveling off of the incidence after 1990
(Pharris-Ciurej et al, 1999). Studies in several countries have
shown that the increasing incidence of testicular cancer is strongly
associated with birth cohort (Hoff Wanderas et al, 1995; Swerdlow
et al, 1998; Liu et al, 1999; McKiernan et al, 1999). 
There is a geographical variation in the incidence rates world-
wide. The highest incidence rates have been noted in Denmark,
Norway and Switzerland, whereas the lowest rates are seen in
Eastern Europe and Asia (Akre, 1999). An almost 10-fold
geographic variation within the Baltic sea countries has been
observed (Adami et al, 1994; Ekbom and Akre, 1998). 
There is concern that the increase in testicular cancer may be
linked to environmental exposure to chemicals, in particular to so-
called endocrine disrupting chemicals (such as dioxin, organochlo-
rine, pesticides and PCBs), and evidence suggests that causal
factors operate early in life, perhaps even in utero (Sharpe and
Shaakebaek, 1993; Sonnenschein and Soto, 1998). Human expo-
sure to chemicals in the environment is unlikely to be evenly
distributed geographically, and if environmental chemicals have
adverse effects on male reproductive health, they may thus give
rise to geographical clustering of disease. 
The aim of this study was to assess temporal trends and analyse
spatial variations in testicular cancer at a small area level across
Great Britain. 
MATERIALS AND METHODS 
Registrations and mortality for testicular cancer (ICD-9 code 186),
ages 20–49, for the whole of England, Wales and Scotland were
extracted from the national post-coded data set held by the UK
Small Area Health Statistics Unit (SAHSU). Cancer registration
data were included between 1974 and 1991 and mortality data
between 1981 and 1997. Ward-level denominator populations
from the 1981 census were used for 1974–1981, 1991 census data
were used from 1991–1997, and linear interpolation of the 1981
and 1991 census counts was used to estimate ward-level popula-
tions for 1982–1990. All small-area population estimates were
then re-scaled to sum to the district-level Registrar General’s
population estimates for each year (Arnold, 1999). 
Spatial variation in incidence was analysed across electoral
wards, 1975 to 1991. All cases in the selected data set had valid
postcodes. Data for 1974 were excluded because postcodes in
Scotland were not established in cancer registration until 1975. For
one ward in England, 42 cases of testicular cancer were recorded.
Further investigation showed that these cases were assigned the
geographical co-ordinates of a local military hospital and, there-
fore, this ward was excluded. No other potentially spurious cluster
was detected. In total, 10 530 wards in Great Britain were included. 
The Carstairs’ index (Carstairs and Morris, 1991) was used as
an index of relative deprivation at the electoral ward level. This
index is a combination of 4 socio-economic indicators from the
census – the percentage of people with no car, in overcrowded
housing, with the head of household in social class IV or V, and the
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percentage of men unemployed. Population density was used as a
measure of urbanization. Wards were grouped into quintiles of
Carstairs’ and population density score. 
Statistical methods 
Temporal trends in incidence and mortality across Great Britain
were examined using 3-year moving averages. For the spatial
analysis, Poisson regression, allowing for over-dispersion, was used
to analyse the ward-level relationship between age-standardized
risk of incident cancer and deprivation, population density and
regional cancer registry. To investigate for registry effects, the
national average was chosen as the reference in the Poisson models.
Statistical significance was assessed using likelihood ratio tests. 
Ward-specific expected numbers of cases were then re-
calculated to standardize for regional cancer registry and depriva-
tion as well as age using national rates. Heterogeneity (excess 
variation) of disease rates was examined using the test described
by Potthoff and Whittinghill (Potthoff and Whittinghill, 1966).
This tests the hypothesis of homogeneity of risk against the alter-
native that the relative risks are drawn from a gamma distribution.
Further analysis used Bayesian disease-mapping techniques to
stabilize risk estimates based on small numbers at ward level
(Mollie, 1996; Wakefield et al, 2000). Bayesian hierarchical
modelling was first used to produce globally smoothed estimates
of risk for all wards in Great Britain (Mollie, 1996). This analysis
takes no account of possible spatially structured variation in risk of
testicular cancer, so we then extended the hierarchical model to
produce estimates of both spatially neutral variation (leading to
global smoothing of risk as before) and spatially structured varia-
tion (leading to local smoothing of risk) (Besag et al, 1991). These
analyses are highly computer intensive. For this reason and for
clarity of presentation, this latter analysis was performed in 2 sub-
regions, covered by the North West Thames registry (in the London
area) and the Yorkshire registry, and were chosen because they
represent a diverse mix of urban, suburban and rural populations. 
RESULTS 
The number of testicular cancer cases registered in Great Britain
increased from 662 in 1974 to 1290 in 1991. Figure 1 shows the
annual rates and 3-year moving averages for testicular cancer inci-
dence (1974–1991) and mortality (1981–1997). The incidence
rose from 6.5 to 11 per 100 000 in the younger age group (20–34,
Figure 1), and from 5.6 to 9.7 per 100 000 in the older age group
(35–49, Figure 1), i.e. almost a doubling of the incidence between
1974 and 1991. In contrast, there was over 50% reduction in
mortality from testicular cancer in both age groups between 1981
(1.0 per 100 000 in the younger and 1.3 per 100 000 in the older
age group) and 1996 (0.4 per 100 000 in both age groups). 
Table 1 shows the relative risks for testicular cancer incidence
by regional cancer registry adjusted for age and deprivation
(Carstairs’ quintiles). This shows significant variation by cancer
registry, with relative risk estimates ranging from 0.8 (95% CI:
0.7–0.8) in NE Thames to 1.3 (95% CI: 1.3–1.4) in Scotland.
There was also a significant association with deprivation: the esti-
mated relative risk of testicular cancer was highest (RR = 1.3,
95% CI 1.2–1.4) in the most affluent compared with the most
deprived quintile, after adjusting for age and cancer registry.
Population density did not significantly improve the fit of 
this model, although it was significantly (P < 0.05) associated
with testicular cancer incidence when deprivation was not
included. 
Table 2 summarizes the numbers of cases and the geographical
variation in the relative risk estimates across wards in Great
Britain. There was significant heterogeneity (Potthoff and
Whittinghill test, P < 0.0001) in risk across wards, i.e. the vari-
ability in the observed relative risks was greater than that expected
by chance if the rate ratios were the same for all areas in the study.
However, as expected, the smoothed relative risks showed consid-
erably less variation between the 5th and 95th percentiles (from
0.93 to 1.10) than the unsmoothed risk estimates (0 to 1.53). When
maps of raw SMRs are plotted they are often dominated by
sampling variability, and the SMRs were therefore ‘smoothed’ in
an attempt to eliminate the spurious noise. The smoothing may be
carried out globally or locally: in the former the rates are assumed
to arise as an independent sample from a probability distribution,
while in the latter spatial dependence is assumed. Global
smoothing corresponds to the belief that all rates are similar while
local smoothing to a belief that rates from areas that are geograph-
ically close are similar. 
Tables 3 and 4 summarize the smoothed relative risks for the
North West Thames and Yorkshire subsets of the data, allowing for
spatially neutral (globally smoothed) and/or spatially structured
(locally smoothed) variation in risk. 
Model comparison was based on the deviance information crite-
rion (DIC) (Spiegelhalter et al, 1998). This is given by a term for
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Figure 1 Annual incidence and mortality rates for testicular cancer in Great
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model complexity, with lower values indicating better fit. The
Bayesian approach allows the posterior probability of any area’s
relative risks exceeding a threshold to be calculated. In NW
Thames, 20 wards showed an estimated relative risk greater than
unity with at least 90% probability, with 2 of these wards having at
least 95% probability of the relative risk exceeding 1.0. There were
no wards in Yorkshire for which the estimated relative risk exceeded
1.0 with at least 90% probability. Figure 2 shows the age- and depri-
vation-adjusted unsmoothed and smoothed relative risks for elec-
toral wards for the Yorkshire and NW Thames subsets (using
smoothed estimates from the best-fitting model for each region).
DISCUSSION 
Recent concerns about possible environmental causes of testicular
cancer have highlighted the need for a current appraisal of its
epidemiology. This study is the first to examine both temporal
trends and geographical variation of testicular cancer at both
regional and small-area scales. 
Time trends 
The present study showed an increasing temporal trend in testic-
ular cancer incidence, with an approximate doubling of the rates in
both age groups from 5–6 per 100 000 in 1974 to 10–11 per
100 000 in 1991. This is consistent with reports from several other
countries, showing that the incidence of testicular cancer is rising
similarly in most Western populations (Adami et al, 1994). In the
west of Scotland, the number of germ cell tumours registered more
than doubled between 1960 and 1990 (Hatton et al, 1995). A study
from Norway reported that the age-standardized incidence for
testis cancer increased from 2.7 per 100 000 in 1955 to 8.5 per
100 000 in 1992 (Hoff Wanderas et al, 1995). In contrast, testicular
cancer mortality showed a sharp decline, in accordance with the
findings from other countries (Devesa et al, 1987; Forman and
Moller, 1994). The reason for the increasing incidence is still
unclear, although environmental chemicals, in particular xenoe-
strogens (Sharpe and Skakkebaek, 1993), as well as infections
(Swerdlow et al, 1987) have been suggested, while the decreasing
mortality must largely reflect advances in treatment, particularly
the introduction of chemotherapy including cis-platinum
(Osterlind, 1986; Chu et al, 1991). 
Table 1 Age-adjusted relative risks for testicular cancer (1975–1991) by
cancer registry and deprivation, expressed as quintiles of the Carstairs’
deprivation index (CQ)a, b
Cancer registry RR 95% CI 
East Anglia 1.13 1.05–1.22 
Mersey 1.00 0.92–1.08 
Northern 0.90 0.84–0.96 
North Western 0.99 0.93–1.06 
Oxford 1.16 1.09–1.24 
South Western 1.11 1.04–1.18 
Trent 0.96 0.91–1.02 
Thames:
NE Thames 0.79 0.73–0.84 
NW Thames 0.88 0.83–0.94 
South Thames 0.92 0.88–0.97 
Yorkshire 1.01 0.95–1.07 
Wessex 1.13 1.06–1.21 
West Midlands 0.92 0.87–0.97 
Scotland 1.32 1.25–1.38 
Wales 0.90 0.83–0.97 
CQ5 (most deprived) 1.00
CQ4 1.14 1.08–1.19 
CQ3 1.15 1.09–1.21 
CQ2 1.23 1.17–1.30 
CQ1 (most affluent) 1.31 1.24–1.38 
a CQ5 was used as a reference. The risk estimates for cancer registry and
deprivation in the table were mutually adjusted. bDispersion parameter = 1.10
(or 10% over dispersion).
Table 2 Spatial variation in relative risks (RR) of testicular cancer adjusted
for age, relative deprivationa and cancer registry across 10 530 electoral
wards in Great Britain (1975–1991), using hierarchical Bayesian methods for
the smoothed estimates 
Observed Expected Unsmoothed RR Smoothed RR
Minimum 0 0.01 0 0.79 
5th percentile 0 0.59 0 0.93 
Median 1 1.15 0.78 0.99 
95th percentile 2 1.98 1.53 1.10 
Maximum 35 9.14 29.20 2.81 
Mean 1.45 1.45 1.01 1.00 
a Using Carstairs’ scores. 
Table 3 Spatial variation in unsmoothed and smoothed relative risksa (RR) of testicular cancer, adjusted for age and deprivation, across 532 electoral wards in
the North West Thames cancer registry, 1975–1991 
Observed Expected Unsmoothed RR Smoothed RR
Spatially Spatially  Spatially 
neutral structured  neutral  &
variation variation structured 
variation
Minimum 0 0.33 0 0.92 0.91 0.89 
5th percentile 0 0.56 0 0.97 0.92 0.90 
Median 1 1.69 0.89 1.00 0.99 0.99 
95th percentile 5 3.38 2.61 1.04  1.15 1.16 
Maximum 8 4.86 5.83 1.14 1.27 1.31 
Mean 1.79 1.79 1.03 1.00 1.00 1.00 
Model fit, DICb – – – 601.6 594.6 593.8 
aUsing hierarchical Bayes’ methods. bDeviance Information Criterion.Spatial variation of testicular cancer in Great Britain 1485
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Geographical variation 
Overall, we found statistically significant geographical differences
in the risk of testicular cancer at regional level, although there was
no particular spatial pattern to the between-registry variation. In
addition there was no clear evidence of local spatial variation at
small area level. 
We standardized the expected counts for this analysis by
registry to account for possible differences between cancer
registries in case ascertainment (Swerdlow, 1986; Best and
Wakefield, 1999). Within registries there may be local varia-
tions in ascertainment that we were not able to account for,
and which would add to the observed variability at small area
scale. 
Table 4 Spatial variation in unsmoothed and smoothed relative risksa (RR) of testicular cancer, adjusted for age and deprivation, across 525 wards in
Yorkshire cancer registry, 1975–1991 
Observed Expected Unsmoothed RR Smoothed RR 
Spatially Spatially  Spatially 
neutral structured neutral  &
variation variation structured 
variation 
Minimum 0 0.20 0 0.95 0.92 0.90 
5th percentile 0 0.36 0 0.98 0.92 0.91 
Median 1 1.10 0.87 1.00 1.01 1.00 
95th percentile 6.6 5.22 2.87 1.03  1.02 1.04 
Maximum 11 8.09 6.30 1.09 1.02 1.11 
Mean 1.85 1.85 0.99 1.00 1.00 0.99 
Model fit, DICb – – – 565.3 566.0 567.2 











Figure 2 Age- and deprivation-adjusted relative risks of testicular cancer, 1975–1991, across electoral wards in Yorkshire cancer registry, unsmoothed risks
(top left) and after smoothing (bottom left), and in the North West Thames cancer registry, unsmoothed risks (top right) and after smoothing (bottom right)1486 MB Toledano et al 
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Further difficulties in interpreting geographical variation
include the long latency periods of this cancer and the effects of
migration. In particular, in-utero exposure is likely to be important
for testicular cancer risk, and it has been shown that the geographic
pattern of incidence is stronger for residence at birth than for resi-
dence at the time of diagnosis (Moller, 1997). The residence of
mothers during pregnancy may be quite different from the resi-
dence of young men at the time of diagnoses. Thus, latency times
and migration patterns are likely to reduce the size of estimated
spatial differences in risk. 
Previous studies have reported geographical variations of testic-
ular cancer incidence. A collaborative study between 9 population-
based cancer registries in countries around the Baltic Sea found a
substantial variation in the age-standardized incidence of testicular
cancer (Adami et al, 1994). There was a 10-fold difference
between the different countries ranging from 0.8 per 100 000
person-years in Lithuania to 7.6 per 100 000 person-years in
Denmark. However, the authors note that the marked hetero-
geneity in incidence between the countries contrasts with a marked
homogeneity within each country as demonstrated from the Nordic
countries (Jensen et al, 1988). The difference between the Nordic
and the Baltic countries suggests that the observed heterogeneity
between countries may reflect differences in registration proce-
dures, rather than true differences. Another possible explanation
would be variation in socio-economic conditions between the
Nordic and the Eastern European countries. However, differences
in registration procedures or socio-economic status cannot readily
explain the 6-fold variation between the Nordic countries, but so
far no plausible explanation for this variation has been given. The
authors also suggest that early exposure to environmental agents
varying between countries may be responsible for the differences
(Adami et al, 1994). So far, however, it has not been possible to
pinpoint any environmental chemical with spatially different
concentration levels between countries. For example, there were
no differences in the DDT-metabolite p,p¢ DDE (an androgen
receptor antagonist) in breast milk, over time between the 4 Nordic
countries (Ekbom et al, 1996). 
In a study of geographical variation at county level in England
and Wales, testicular cancer risk tended to be higher in the south of
England amongst the 0–49 year age group, but there was no
consistent pattern (Swerdlow and dos Santos Silva, 1993). We
found the lowest risks in North East Thames (RR = 0.79, 95% CI:
0.73–0.84) and the highest risks in Scotland (RR = 1.32, 95% CI:
1.25–1.38), but no consistent north–south gradient. The lower risk
in North East Thames may, at least partly, reflect relative under-
ascertainment, which was a particular problem with this registry
prior to 1986 (Best and Wakefield, 1999; Bullard et al, 2000). 
We found significantly higher testicular cancer risk with
decreasing relative deprivation at the small-area level, in contrast
to previous studies at individual level, which have found no
evidence of any social class effect (UK Testicular Cancer Study
Group, 1994). 
In our study, population density was associated with testicular
cancer incidence but was no longer significant with adjustment for
deprivation, suggesting that any urban–rural difference was
reflecting differences in socio-economic status at a small-area
scale. Similarly, a recent Dutch study found no urban–rural differ-
ences, although there was a suggestion of geographical clustering in
a rural area in the north of the Netherlands (Sonneveld et al, 1999). 
Our analysis within the Yorkshire and North West Thames
registries did not suggest any marked geographical clustering of
testicular cancer incidence at the level of electoral wards. While it
is difficult to judge whether the findings for these 2 registries are
representative, the 5th to 95th percentile range of smoothed risk
estimates across each region in the Bayesian analysis was similar
to that for Britain as a whole. 
Interpretation of geographical variations is complicated by a
number of factors. These include variations in data quality
between and within regions, long latency periods and migration
effects, which are likely to reduce the ability to detect any true
variation. Nonetheless, the absence of any marked geographical
variability at small area scale argues against a geographically
varying environmental factor operating strongly in the aetiology of
testicular cancer. However, this does not preclude an important
role of a ubiquitous (environmental) exposure, which may have
strong variability at the national level. 
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